Carregant...

Neonatal Fc receptor and IgG-based therapeutics

The majority of potent new biologics today are IgG-based molecules that have demonstrated tissue-targeting specificity with favorable clinical response. Several factors determine the efficacy of these products, including target specificity, serum half-life and effector functions via complement-depen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kuo, Timothy T, Aveson, Victoria G
Format: Artigo
Idioma:Inglês
Publicat: Landes Bioscience 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3225846/
https://ncbi.nlm.nih.gov/pubmed/22048693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.3.5.16983
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!